MITCHELL HEIDE: Open Payments
NPI 1073023248 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 56 payments from 18 companies in 2025. Trend: 2023 $1,405 · 2024 $1,216 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $224 |
| Sumitomo Pharma America, Inc. | 6 | $148 |
| TOLMAR, INC. | 3 | $121 |
| Astellas Pharma US Inc | 1 | $115 |
| Merck Sharp & Dohme LLC | 1 | $112 |
| Boston Scientific Corporation | 3 | $89 |
| PFIZER INC. | 4 | $88 |
| Endo USA, Inc. | 5 | $85 |
| Janssen Biotech, Inc. | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
Products named: BOTOX, ORGOVYX, Padcev, KEYTRUDA, ELIGARD, XTANDI, PLUVICTO, AVEED.
Industry payments across AZ — which companies pay providers there.
